Since semaglutide changes how you digest food, side effects may occur as your body gets used to the new drug
doi: 10.3389/fmed.2025.1526090 Received 11 November 2024 Accepted 30 January 2025 Published 14 February 2025 Volume 12 - 2025 Edited by Anil Kumar Pasupulati, University of Hyderabad, India Reviewed by Nasar Alwahaibi, Sultan Qaboos University, Oman Pedro Paulo Scariot, Sao Francisco University, Brazil Updates Copyright 2025 Boima, Agyekum, Ganatra, Agyekum, Kwakyi, Inusah, Ametefe and Adu
After taking individual risk factors into account, the risk for non-live birth was 29.7% with medication continuation versus 27.1% with non-continuation, a difference that was not deemed statistically significant
Takie wyniki s zachcajce i wskazuj na potencja semaglutydw w leczeniu powizanych schorze metabolicznych